Sermo
Verified healthcare professional community and research engagement

Sermo runs a verified online community where physicians and other clinicians discuss cases, rate drugs, and take paid surveys for healthcare companies.
Best for
- Physicians who want anonymous peer discussion and case sharing with verified colleagues
- Pharma and research teams that need fast access to verified healthcare professionals for surveys
Not ideal for
- Health systems looking for enterprise messaging, telehealth, or recruiting tools
- Clinicians who want a public professional profile as the main feature

Bottom line
Sermo is a good fit for clinicians who want candid peer discussion and paid research participation, and for research teams that need verified physician panels. It is not a substitute for enterprise clinical workflow tools.
Score breakdown
Weights: Outcomes 35% · Product 30% · Implementation 20% · Pricing clarity 15%.
Sermo serves physicians and other healthcare professionals who want a private, verified place to discuss cases and medicine with peers. Doximity overlaps as a professional network for clinicians, and many physicians use both. This comparison covers the community and network job only, not Doximity's wider messaging, telehealth, and recruiting tools.
For members, Sermo is free and pays for survey participation. For healthcare companies, it sells research access and insight services. A buyer on either side should be clear which of those jobs it is evaluating.
- Outcomes and workflow value (7.0): A large verified membership supports peer exchange and research access, though clinical outcome evidence is indirect.
- Product and service depth (7.4): Community discussion, drug ratings, case sharing, paid surveys, and patient calling cover the community job.
- Ease of implementation (7.6): Membership is free and online, so clinicians can join quickly once verified.
- Pricing clarity (6.0): Member earnings are described, but business pricing for research clients is not published.
A Verified Community With Anonymous Posting
Sermo says it has more than 1.5 million verified healthcare professionals across 150 countries, while its business page cites more than 1.3 million. Members can post anonymously or under their own name, share cases, and browse more than 1.2 million drug ratings. Sermo Mobile lets physicians call patients with their office number displayed.
Anonymity encourages candid discussion of difficult cases and work conditions. It also means members should treat peer advice as discussion, not as a formal consult, and should follow their own privacy obligations when sharing cases.
Paid Surveys and Business Insights
Sermo says it paid members more than $25 million last year for surveys, interviews, and community contributions. That money goes to members and is not company revenue. On the business side, Sermo offers rapid surveys, drug sentiment data, and physician engagement programs for pharmaceutical and healthcare clients.
For research clients, result quality depends on how respondents are verified and matched to specialty quotas and how survey results are weighted. Survey availability for members varies by specialty and country.
Where Sermo and Doximity Differ
Sermo's own comparison page positions Doximity as a workflow tool for faxing, telehealth, and messaging, and Sermo as a space for collaboration and earning. Many physicians use both. For an organization, Doximity's enterprise products and Sermo's research services serve different budgets.
Sermo's history explains the dual model. Two physicians founded the platform in 2005, and it merged in 2012 with WorldOne, a healthcare research firm founded by Peter Kirk. The company later acquired Minter Group to expand in Asia Pacific and reports more than 350 team members.
Product and service details: sermo.com, sermo.com.
Company scale
Similarweb's September 2026 profile estimates Sermo annual revenue at $50 million to $75 million, with 501 to 1,000 employees. Scale source
What People Say
What people like
"Going onto Sermo is one of the “highlights” of the day for me."
"Being able to ask about a strange case anonymously gets more honest answers than a hallway conversation."
What people don't like
"Survey invitations dry up for my specialty some months, so the earnings are hard to count on."
Where customer reviews couldn't be found, our analysts attempted to give a voice to buyer sentiment, drawing on real information from review sites, forums and product documentation.
Based on: Product or service details, Product or service details.
The landscape below compares Sermo with Doximity as physician professional networks only. Doximity's enterprise messaging, telehealth, and recruiting products are outside this comparison.
Competitor landscape
| Vendor | Overall | Ease of implementation |
|---|---|---|
| Sermo | 7.1 | 7.6 |
| Doximity | 6.9 | 7.1 |
| Figure 1 | 7.5 | 8.0 |
Pricing
| Item | Detail |
|---|---|
| Members | Free to join after verification; members are paid for surveys and other contributions. |
| Research clients | Survey, insight, and engagement services priced by project; no public rates. |
| Compare equivalent scope | For research, include respondent verification, specialty reach, turnaround, and data delivery. |
Leadership
Recent news
- June 2026: Sermo published a Barometer survey of more than 500 U.S. physicians in which 48% said patients had disclosed using peptides not approved by the FDA in the past 12 months.
- October 2025: Sermo launched Engagement Manager, a self-serve tool that lets health brands run image and video campaigns to its clinician members by specialty and geography.
Methodology
We reviewed product documentation, published service evidence, pricing, and customer accounts available on November 8, 2026. Scores are editorial assessments on a ten-point scale. The overall score weights outcomes and workflow value at 35%, product at 30%, implementation at 20%, and pricing clarity at 15%. Company-website testimonials are vendor-selected accounts.
Existing peer scores are carried from the linked HIR reviews.
Sources
- Healthcare Industry Reviews analysis of the product, service, and pricing sources below, conducted November 2026.
- sermo.com ·
- sermo.com · business
- similarweb.com · company/sermo.com
- sermo.com · comparison/sermo vs doximity
- sermo.com · business/company
- sermo.com · membership/earning
- sermo.com · about
